All Stories

  1. Response of Cancer Stem Cells and Human Skin Fibroblasts to Picosecond-Scale Electron Irradiation at 1010 to 1011 Gy/s
  2. Most DNA repair defects do not modify the relationship between relative biological effectiveness and linear energy transfer in CRISPR‐edited cells
  3. High-LET radiation induces large amounts of rapidly-repaired sublethal damage
  4. Validation of In Vitro Trained Transcriptomic Radiosensitivity Signatures in Clinical Cohorts
  5. Characterization of Intrinsic Radiation Sensitivity in a Diverse Panel of Normal, Cancerous and CRISPR-Modified Cell Lines
  6. Modelling oxygen effects on the in- and out-of-field radiosensitivity of cells exposed to intensity-modulated radiation fields
  7. Investigating the potential contribution of inter-track interactions within ultra-high dose-rate proton therapy
  8. Cellular irradiations with laser-driven carbon ions at ultra-high dose rates
  9. DNA Repair Inhibitors Potentiate Fractionated Radiotherapy More Than Single-Dose Radiotherapy in Breast Cancer Cells
  10. A computational approach to quantifying miscounting of radiation-induced double-strand break immunofluorescent foci
  11. High-dose femtosecond-scale gamma-ray beams for radiobiological applications
  12. RadSigBench: a framework for benchmarking functional genomics signatures of cancer cell radiosensitivity
  13. Evaluating Iodine-125 DNA Damage Benchmarks of Monte Carlo DNA Damage Models
  14. Investigating spatial fractionation and radiation induced bystander effects: a mathematical modelling approach
  15. A Brief Overview of the Preclinical and Clinical Radiobiology of Microbeam Radiotherapy
  16. Theranostic AGuIX nanoparticles as radiosensitizer: A phase I, dose-escalation study in patients with multiple brain metastases (NANO-RAD trial)
  17. A Mechanistic DNA Repair and Survival Model (Medras): Applications to Intrinsic Radiosensitivity, Relative Biological Effectiveness and Dose-Rate
  18. TOPAS a tool to evaluate the impact of cell geometry and radionuclide on alpha particle therapy
  19. Oxygen enhancement ratios of cancer cells after exposure to intensity modulated x-ray fields: DNA damage and cell survival
  20. Proton RBE models: commonalities and differences
  21. Advances in modelling gold nanoparticle radiosensitization using new Geant4-DNA physics models
  22. Cardiac sub-volume targeting demonstrates regional radiosensitivity in the mouse heart
  23. Roadmap for metal nanoparticles in radiation therapy: current status, translational challenges, and future directions
  24. History and current perspectives on the biological effects of high-dose spatial fractionation and high dose-rate approaches: GRID, Microbeam & FLASH radiotherapy
  25. Effects of Gadolinium MRI Contrast Agents on DNA Damage and Cell Survival when Used in Combination with Radiation
  26. Targeted Alpha Therapy: Current Clinical Applications
  27. Cellular Response to Proton Irradiation: A Simulation Study with TOPAS-nBio
  28. A parameter sensitivity study for simulating DNA damage after proton irradiation using TOPAS-nBio
  29. A Quantitative Analysis of the Role of Oxygen Tension in FLASH Radiation Therapy
  30. Intensity Modulated Radiation Fields Induce Protective Effects and Reduce Importance of Dose-Rate Effects
  31. Using the Proton Energy Spectrum and Microdosimetry to Model Proton Relative Biological Effectiveness
  32. Predicting In Vitro Cancer Cell Survival Based on Measurable Cell Characteristics
  33. Mechanistic Modeling of Radium-223 Treatment of Bone Metastases
  34. Preclinical Evaluation of Dose-Volume Effects and Lung Toxicity Occurring In and Out-of-Field
  35. Mechanistic Modelling of Radiation Responses
  36. The linear quadratic model: usage, interpretation and challenges
  37. A New Standard DNA Damage (SDD) Data Format
  38. LET-weighted doses effectively reduce biological variability in proton radiotherapy planning
  39. AGuIX® from bench to bedside—Transfer of an ultrasmall theranostic gadolinium-based nanoparticle to clinical medicine
  40. Proton relative biological effectiveness (RBE): a multiscale problem
  41. Toward A variable RBE for proton beam therapy
  42. Investigation of dose-rate effects and cell-cycle distribution under protracted exposure to ionizing radiation for various dose-rates
  43. The Radiobiology of Proton Therapy: Challenges and Opportunities Around Relative Biological Effectiveness
  44. Microbeam evolution: From single cell irradiation to preclinical studies
  45. Small field dosimetry for the small animal radiotherapy research platform (SARRP)
  46. The Impact of Hypoxia on Out-of-Field Cell Survival after Exposure to Modulated Radiation Fields
  47. Dual effects of radiation bystander signaling in urothelial cancer: purinergic-activation of apoptosis attenuates survival of urothelial cancer and normal urothelial cells
  48. A general mechanistic model enables predictions of the biological effectiveness of different qualities of radiation
  49. A novel CBCT-based method for derivation of CTV-PTV margins for prostate and pelvic lymph nodes treated with stereotactic ablative radiotherapy
  50. Comparing stochastic proton interactions simulated using TOPAS-nBio to experimental data from fluorescent nuclear track detectors
  51. A mechanistic study of gold nanoparticle radiosensitisation using targeted microbeam irradiation
  52. Prostate cancer treated with brachytherapy; an exploratory study of dose-dependent biomarkers and quality of life
  53. An overview of current practice in external beam radiation oncology with consideration to potential benefits and challenges for nanotechnology
  54. Dependence of gold nanoparticle radiosensitization on cell geometry
  55. Mitochondria as a target for radiosensitisation by gold nanoparticles
  56. Modelling responses to spatially fractionated radiation fields using preclinical image-guided radiotherapy
  57. Mechanistic Modelling of DNA Repair and Cellular Survival Following Radiation-Induced DNA Damage
  58. Dose enhancement effects to the nucleus and mitochondria from gold nanoparticles in the cytosol
  59. Protein disulphide isomerase as a target for nanoparticle-mediated sensitisation of cancer cells to radiation
  60. Imaging and radiation effects of gold nanoparticles in tumour cells
  61. Optimising element choice for nanoparticle radiosensitisers
  62. Roadmap to Clinical Use of Gold Nanoparticles for Radiation Sensitization
  63. Impact of fractionation on out-of-field survival and DNA damage responses following exposure to intensity modulated radiation fields
  64. Gold nanoparticle induced vasculature damage in radiotherapy: Comparing protons, megavoltage photons, and kilovoltage photons
  65. Time and Cell Type Dependency of Survival Responses in Co-cultured Tumor and Fibroblast Cells after Exposure to Modulated Radiation Fields
  66. Cellular signalling effects in high precision radiotherapy
  67. Biological modeling of gold nanoparticle enhanced radiotherapy for proton therapy
  68. Comparing gold nano-particle enhanced radiotherapy with protons, megavoltage photons and kilovoltage photons: a Monte Carlo simulation
  69. Conventional in vivo irradiation procedures are insufficient to accurately determine tumor responses to non-uniform radiation fields
  70. The role of mitochondrial function in gold nanoparticle mediated radiosensitisation
  71. The use of theranostic gadolinium-based nanoprobes to improve radiotherapy efficacy
  72. Relative Biological Effectiveness Variation Along Monoenergetic and Modulated Bragg Peaks of a 62-MeV Therapeutic Proton Beam: A Preclinical Assessment
  73. Investigation into the radiobiological consequences of pre-treatment verification imaging with megavoltage X-rays in radiotherapy
  74. Investigating the Potential Impact of Four-dimensional Computed Tomography (4DCT) on Toxicity, Outcomes and Dose Escalation for Radical Lung Cancer Radiotherapy
  75. Gold nanoparticle cellular uptake, toxicity and radiosensitisation in hypoxic conditions
  76. Implications of Intercellular Signaling for Radiation Therapy: A Theoretical Dose-Planning Study
  77. Investigating the influence of respiratory motion on the radiation induced bystander effect in modulated radiotherapy
  78. Bystander Signalling: Exploring Clinical Relevance Through New Approaches and New Models
  79. Antiproton induced DNA damage: proton like in flight, carbon-ion like near rest
  80. Inverse planned constant dose rate volumetric modulated arc therapy (VMAT) as an efficient alternative to five-field intensity modulated radiation therapy (IMRT) for prostate
  81. CORRIGENDUM: Biological consequences of nanoscale energy deposition near irradiated heavy atom nanoparticles
  82. An in vitro study of the radiobiological effects of flattening filter free radiotherapy treatments
  83. A Kinetic-Based Model of Radiation-Induced Intercellular Signalling
  84. Gold Nanoparticles for Imaging and Radiotherapy
  85. Relative biological effectiveness (RBE) and out-of-field cell survival responses to passive scattering and pencil beam scanning proton beam deliveries
  86. In-vitro investigation of out-of-field cell survival following the delivery of conformal, intensity-modulated radiation therapy (IMRT) and volumetric modulated arc therapy (VMAT) plans
  87. A Computational Model of Cellular Response to Modulated Radiation Fields
  88. DNA Damage Responses following Exposure to Modulated Radiation Fields
  89. Cell type-dependent uptake, localization, and cytotoxicity of 1.9 nm gold nanoparticles
  90. Dose, dose-rate and field size effects on cell survival following exposure to non-uniform radiation fields
  91. Physical basis and biological mechanisms of gold nanoparticle radiosensitization
  92. Cold atmospheric pressure plasma jets: Interaction with plasmid DNA and tailored electron heating using dual-frequency excitation
  93. Comment on ‘Implications on clinical scenario of gold nanoparticle radiosensitization in regards to photon energy, nanoparticle size, concentration and location’
  94. Energy Dependence of Gold Nanoparticle Radiosensitization in Plasmid DNA
  95. Nanodosimetric effects of gold nanoparticles in megavoltage radiation therapy
  96. Biological consequences of nanoscale energy deposition near irradiated heavy atom nanoparticles
  97. A Robust Curve-Fitting Procedure for the Analysis of Plasmid DNA Strand Break Data from Gel Electrophoresis
  98. Characterization and parametrization in terms of atomic number of x-ray emission from K -shell filling during ion-surface interactions
  99. Cell-Specific Radiosensitization by Gold Nanoparticles at Megavoltage Radiation Energies
  100. Cold atmospheric pressure plasma jet interactions with plasmid DNA
  101. Variance reduction of Monte-Carlo radiation transport via scalar flux continuity — A practical radiation treatment planning approach
  102. Evaluation of cytotoxicity and radiation enhancement using 1.9 nm gold particles: potential application for cancer therapy
  103. Dielectronic recombination in He-like, Li-like, and Be-like highly charged ions in the KLL and KLM manifolds
  104. Radiotherapy in the presence of contrast agents: a general figure of merit and its application to gold nanoparticles